GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blue Jet Healthcare Ltd (BOM:544009) » Definitions » EBITDA

Blue Jet Healthcare (BOM:544009) EBITDA : ₹3,337 Mil (TTM As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Blue Jet Healthcare EBITDA?

Blue Jet Healthcare's EBITDA for the three months ended in Dec. 2024 was ₹1,373 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 was ₹3,337 Mil.

During the past 12 months, the average EBITDA Growth Rate of Blue Jet Healthcare was 26.90% per year. During the past 3 years, the average EBITDA Growth Rate was 5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 4 years, the highest 3-Year average EBITDA Growth Rate of Blue Jet Healthcare was 5.90% per year. The lowest was 5.90% per year. And the median was 5.90% per year.

Blue Jet Healthcare's EBITDA per Share for the three months ended in Dec. 2024 was ₹7.92. Its EBITDA per share for the trailing twelve months (TTM) ended in Dec. 2024 was ₹19.25.

During the past 12 months, the average EBITDA per Share Growth Rate of Blue Jet Healthcare was 27.00% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 5.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 4 years, the highest 3-Year average EBITDA per Share Growth Rate of Blue Jet Healthcare was 5.90% per year. The lowest was 5.90% per year. And the median was 5.90% per year.


Blue Jet Healthcare EBITDA Historical Data

The historical data trend for Blue Jet Healthcare's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blue Jet Healthcare EBITDA Chart

Blue Jet Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24
EBITDA
2,090.08 2,682.71 2,430.42 2,483.45

Blue Jet Healthcare Quarterly Data
Mar21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 515.93 618.95 529.78 815.60 1,372.55

Competitive Comparison of Blue Jet Healthcare's EBITDA

For the Biotechnology subindustry, Blue Jet Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blue Jet Healthcare's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Blue Jet Healthcare's EV-to-EBITDA falls into.


;
;

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Blue Jet Healthcare's EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Blue Jet Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Mar. 2024, Blue Jet Healthcare's EBITDA was ₹2,483 Mil.

Blue Jet Healthcare's EBITDA for the quarter that ended in Dec. 2024 is calculated as

Blue Jet Healthcare's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Dec. 2024, Blue Jet Healthcare's EBITDA was ₹1,373 Mil.

EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹3,337 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Blue Jet Healthcare  (BOM:544009) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Blue Jet Healthcare EBITDA Related Terms

Thank you for viewing the detailed overview of Blue Jet Healthcare's EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Blue Jet Healthcare Business Description

Traded in Other Exchanges
Address
701, 702, 7th Floor, Plot No. 1 & 2, Bhumiraj Costarica, Sector 18, Sanpada, Navi Mumbai, MH, IND, 400 705
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients.

Blue Jet Healthcare Headlines

No Headlines